MyFinsight
Home
About
Contact
CRESCENT BIOPHARMA, INC. (CBIO)
For the quarter ending 2025-06-30, CBIO made $313K in revenue. -$21,790K in net income. Net profit margin of -6961.66%.
Overview
Revenue
$313K
Net Income
-$21,790K
Net Profit Margin
-6961.66%
Unit: Thousand (K) dollars
Revenue Breakdown
Interest income
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
2025-06-30
Interest income
313
Interest expense
1,073
Total other expense
-760
Loss from operations
-21,030
Net loss
-21,790
Net loss and comprehensive loss
-21,790
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Income Statement
Download
Download image
Net loss and
comprehensive loss
-$21,790K
Net loss
-$21,790K
Loss from operations
-$21,030K
Total other expense
-$760K
Interest income
$313K
Interest expense
$1,073K
Subscribe for Financial Insights